Advertisement

The Latest

From the Elevance-Blue Cross Blue Shield of Louisiana deal put on hold again to Cigna reaching a deal to sell its Medicare business, here are nine payer mergers and acquisitions updates Becker's has reported since Jan. 29: 

It has been a busy few weeks for Medicare Advantage policy. CMS proposed a slight cut in benchmark rates, and payer executives were split on the impact of rising costs in the business. 

Medicaid redeterminations began in April 2023, and all major payers have released their 2023 earnings, revealing which recorded the largest enrollment losses in the Medicaid market.

The Cigna Group is buying back $3.2 billion in common stock through accelerated repurchase agreements with Deutsche Bank and Bank of America, the company announced Feb. 15. 

Most private investments in the Medicare Advantage space go to companies specializing in marketing and selling MA plans, according to a Feb. 13 report from the Private Equity Stakeholder Project. 

Advertisement